SLAUGHTERS TAKES LEAD ON PHARMA MEGA DEAL
Slaughter and May has acted opposite Cravath, Swaine & Moore as Johnson & Johnson made a $30bn offer to buy Swiss-based biopharma company Actelion Pharmaceuticals earlier this year. Slaughters advised along with Zürich-based Niederer Kraft & Frey and Wachtell, Lipton, Rosen & Katz for the takeover target, as Cravath advised Johnson.
Subscriber Access
You must be logged in to view full premium content.
